Baxter International | BAX - Actif À Court Terme

Prix De L'Action
17.08
Variation Quotidienne
-0.32 -1.84%
Mensuellement
-17.65%
Annuel
-50.99%
Q1 Prévisions
16.87




Actif À Court Terme Changement Date
Abbott USD 26B 1.16B 2025-12
AngioDynamics USD 172.27M 3.09M 2025-02
Artivion USD 358.08M 20.58M 2025-12
AtriCure USD 322.52M 21.41M 2025-12
Avanos Medical USD 355.4M 4M 2025-12
Baxter International USD 6.87B 61M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Cooper Companies USD 2.13B 27.4M 2025-12
Dexcom USD 4.03B 1.19B 2025-12
Edwards Lifesciences USD 6.36B 218.3M 2025-09
Fresenius EUR 12.06B 1.18B 2025-09
Globus Medical USD 2.13B 201.25M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
ICU Medical USD 1.19B 16.74M 2025-12
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.91B 54.6M 2025-12
Integra LifeSciences USD 1.16B 15.96M 2025-12
Intuitive Surgical USD 12.4B 927.3M 2025-12
J&J USD 55.62B 1.01B 2025-12
Laboratory Of America USD 4.02B 58.3M 2025-12
Masimo USD 926M 122.3M 2025-12
Medtronic USD 24B 773M 2025-09
Merit Medical Systems USD 1.04B 54.62M 2025-12
Quest Diagnostics USD 2.38B 29M 2025-12
Smith & Nephew USD 4.63B 169M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Tandem Diabetes Care USD 618.14M 1.2M 2025-12
Teleflex USD 1.94B 47.65M 2025-12
Terumo JPY 815.56B 71.48B 2025-12
Zimmer Biomet Holdings USD 5.12B 715M 2025-12